Literature DB >> 12631820

The European Sero-Epidemiology Network.

K Osborne, J Weinberg, E Miller.   

Abstract

The purpose of serological surveillance is to monitor levels of immunity to particular diseases within a population in order to enhance the quality of information on which public health measures, such as vaccination programmes, are based. Serological surv

Entities:  

Year:  1997        PMID： 12631820     DOI： 10.2807/esm.02.04.00167-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  18 in total

Review 1.  The role of seroepidemiology in the comprehensive surveillance of vaccine-preventable diseases.

Authors:  Sarah E Wilson; Shelley L Deeks; Todd F Hatchette; Natasha S Crowcroft
Journal:  CMAJ       Date:  2011-11-14       Impact factor: 8.262

2.  Prevalence of mumps antibodies in the Israeli population in relation to mumps vaccination policy and incidence of disease.

Authors:  Kh Muhsen; Y Aboudy; E Mendelson; M S Green; D Cohen
Journal:  Epidemiol Infect       Date:  2007-07-03       Impact factor: 2.451

3.  Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia.

Authors:  A Tischer; N Andrews; G Kafatos; A Nardone; G Berbers; I Davidkin; Y Aboudy; J Backhouse; C Barbara; K Bartha; B Bruckova; A Duks; A Griskevicius; L Hesketh; K Johansen; L Jones; O Kuersteiner; E Lupulescu; Z Mihneva; M Mrazova; F De Ory; K Prosenc; F Schneider; A Tsakris; M Smelhausova; R Vranckx; M Zarvou; E Miller
Journal:  Epidemiol Infect       Date:  2007-03-30       Impact factor: 2.451

4.  Towards elimination: measles susceptibility in Australia and 17 European countries.

Authors:  Nick Andrews; Annedore Tischer; Annette Siedler; Richard G Pebody; Christopher Barbara; Suzanne Cotter; Arnis Duks; Nina Gacheva; Kriz Bohumir; Kari Johansen; Joel Mossong; Fernando de Ory; Katarina Prosenc; Margareta Sláciková; Heidi Theeten; Marios Zarvou; Adriana Pistol; Kalman Bartha; Dani Cohen; Jo Backhouse; Algirdas Griskevicius
Journal:  Bull World Health Organ       Date:  2008-03       Impact factor: 9.408

5.  Seropositivity of measles antibodies in the Israeli population prior to the nationwide 2018 - 2019 outbreak.

Authors:  Ravit Bassal; Victoria Indenbaum; Rakefet Pando; Tal Levin; Eilat Shinar; Doron Amichay; Mira Barak; Anat Ben-Dor; Adina Bar Haim; Ella Mendelson; Dani Cohen; Tamy Shohat
Journal:  Hum Vaccin Immunother       Date:  2020-10-29       Impact factor: 3.452

6.  Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets.

Authors:  Anthony Nardone; Annedore Tischer; Nick Andrews; Jo Backhouse; Heidi Theeten; Nina Gatcheva; Marios Zarvou; Bohumir Kriz; Richard G Pebody; Kalman Bartha; Darina O'Flanagan; Dani Cohen; Arnis Duks; Algirdas Griskevicius; Joel Mossong; Christopher Barbara; Adrianna Pistol; Margareta Slaciková; Katarina Prosenc; Kari Johansen; Elizabeth Miller
Journal:  Bull World Health Organ       Date:  2008-02       Impact factor: 9.408

7.  Seroprevalence of cytomegalovirus infection in France in 2010.

Authors:  D Antona; A Lepoutre; L Fonteneau; C Baudon; F Halftermeyer-Zhou; Y LE Strat; D Lévy-Bruhl
Journal:  Epidemiol Infect       Date:  2017-02-07       Impact factor: 4.434

8.  Comparative seroepidemiology of diphtheria in six European countries and Israel.

Authors:  P di Giovine; G Kafatos; A Nardone; N Andrews; R M Ölander; G Alfarone; K Broughton; D Cohen; B Kriz; I Mikova; D O'Flanagan; F Schneider; I Selga; L Valinsky; I Velicko; I Karacs; R Pebody; C von Hunolstein
Journal:  Epidemiol Infect       Date:  2012-02-24       Impact factor: 4.434

9.  Estimating seroprevalence of vaccine-preventable infections: is it worth standardizing the serological outcomes to adjust for different assays and laboratories?

Authors:  G Kafatos; N Andrews; K J McConway; C Anastassopoulou; C Barbara; F De Ory; K Johansen; J Mossong; K Prosenc; R Vranckx; A Nardone; R Pebody; P Farrington
Journal:  Epidemiol Infect       Date:  2014-11-25       Impact factor: 4.434

10.  Heterogeneity in regional notification patterns and its impact on aggregate national case notification data: the example of measles in Italy.

Authors:  John R Williams; Piero Manfredi; Alisa R Butler; Marta Ciofi Degli Atti; Stefania Salmaso
Journal:  BMC Public Health       Date:  2003-07-18       Impact factor: 3.295
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.